GM103 drug page Clinical trials

Trials with GM103

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
125Planned patients

Showing 1–1 of 1

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Recruiting Phase 1 125 patients NCT06265025

The purpose of this study is to measure safety, tolerability, and preliminary antitumor efficacy of GM103 administered alone and in combination with pembrolizumab in patients with locally advanced, unresectable, refractory and/or metastati…

South Korea Feb 2024 – Oct 2028 Interventional
Combined with: Pembrolizumab

Where the recruiting trials are